What is the plan of care for a 12-month-old with recurrent acute otitis media (AOM) being treated with cefdinir (14 mg/kg/day x 7 days), and who has developed hives after ingestion of whole milk and peanut butter, with a history of allergic reaction to amoxicillin (amox)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Plan of Care for 12-Month-Old with Recurrent AOM, Amoxicillin Rash, and New-Onset Hives

Immediate Action: Discontinue Cefdinir and Reassess Allergies

Stop cefdinir immediately and do not restart it—this child has a documented penicillin allergy (amoxicillin rash), and cephalosporins carry cross-reactivity risk that should not be ignored in a child who has now developed hives after multiple exposures. 1, 2

Critical Allergy Assessment

  • The amoxicillin rash at 7 days was likely a true allergic reaction, not a benign viral exanthem, especially given the subsequent hives after cefdinir exposure 1
  • Cross-reactivity between penicillins and cephalosporins occurs in up to 10% of penicillin-allergic patients, though newer data suggest lower rates with second/third-generation cephalosporins 1, 2
  • However, the FDA label explicitly warns that cefdinir should be given with caution to penicillin-sensitive patients 2
  • The hives may be from cefdinir (cross-reactivity), peanut butter (first exposure), or whole milk (new allergen at 12 months) 1

Immediate Management Steps

1. Allergy Workup:

  • Refer to pediatric allergist urgently for formal evaluation of penicillin allergy, peanut allergy, and milk allergy 1
  • Document the exact nature of the amoxicillin reaction (timing, distribution, associated symptoms) 2
  • Hold all new food introductions until allergy evaluation is complete 1

2. Alternative Antibiotic for Current AOM:

Switch to azithromycin 10 mg/kg on day 1, then 5 mg/kg daily for days 2-5 (total 5 days), as this is the safest non-beta-lactam option for a child with documented penicillin allergy and suspected cephalosporin cross-reactivity 1, 3

  • Azithromycin is recommended for type I hypersensitivity reactions to penicillin 3
  • While macrolides have higher pneumococcal resistance rates, they are the appropriate choice when beta-lactams are contraindicated 3
  • For a 12-month-old child, a 10-day antibiotic course is required per AAP guidelines 1, 4

3. Correct the Dosing Error:

  • The prescribed cefdinir dose of 14 mg/kg/day for 7 days was incorrect on two counts:
    • Children under 2 years require 10 days of therapy, not 7 days 1, 4
    • The 14 mg/kg/day dose is appropriate, but duration was inadequate 2

Management of Recurrent AOM

This child meets criteria for recurrent AOM if there have been 3+ episodes in 6 months or 4+ episodes in 12 months with at least 1 in the preceding 6 months 1

Recurrent AOM Prevention Strategy

1. Risk Factor Modification (implement immediately):

  • Eliminate tobacco smoke exposure completely 1, 4
  • Reduce or eliminate pacifier use after 6 months of age 4
  • Avoid supine bottle feeding 4
  • Consider reducing daycare attendance if feasible 1, 4
  • Ensure pneumococcal (PCV-13) and annual influenza vaccination are up to date 4

2. Avoid Antibiotic Prophylaxis:

  • Do not use prophylactic antibiotics—the AAP explicitly recommends against this due to minimal benefit, adverse effects, and contribution to bacterial resistance 1, 4
  • Prophylaxis prevents only 1 episode per child-year and has no lasting benefit after cessation 1

3. Consider Tympanostomy Tubes:

  • Refer to pediatric otolaryngology for evaluation for tympanostomy tube placement if recurrent AOM criteria are met 1
  • Tubes reduce AOM episodes during the 6-month period they remain patent 1
  • This is an option, not a mandate—requires shared decision-making with parents 1

Follow-Up Protocol

1. Short-term (48-72 hours):

  • Reassess clinical response to azithromycin 1, 3
  • If no improvement, consider tympanocentesis with culture to guide therapy, or empiric switch to intramuscular ceftriaxone 50 mg/kg daily for 3 days (if allergy evaluation suggests cephalosporin is safe) 1, 4

2. Medium-term (2-4 weeks):

  • Complete allergy evaluation with allergist 1
  • Confirm resolution of middle ear effusion (60-70% will have persistent effusion at 2 weeks, which is normal and does not require antibiotics) 1
  • Document whether this episode qualifies as recurrent AOM based on total episode count 1

3. Long-term:

  • If recurrent AOM is confirmed, proceed with ENT referral for tube consideration 1
  • Establish clear antibiotic allergy list based on formal testing 1
  • Reintroduce peanut butter and whole milk only after allergy clearance 1

Critical Pitfalls to Avoid

  • Never use cefdinir or other cephalosporins again until formal allergy testing confirms safety 1, 2
  • Do not use 7-day antibiotic courses in children under 2 years—this increases treatment failure risk 1, 4
  • Do not prescribe prophylactic antibiotics for recurrent AOM—this is explicitly not recommended 1, 4
  • Do not ignore the hives—this requires urgent allergy evaluation to determine the culprit (drug vs. food) 1, 2
  • Do not assume middle ear effusion at 2-4 weeks post-treatment represents treatment failure—this is otitis media with effusion (OME) and requires monitoring, not antibiotics 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.